Xigen Company
Xigen is a Swiss biopharmaceutical company that was established in 2002 as a spin-off from the University Hospital of Lausanne. The company's CEO and co-founder, Dr. Christophe Bonny, is a well-known molecular biologist who specializes in intracellular peptides and signaling.
Connections
Headquarters:
Epalinges, Vaud, Switzerland
Funding Status:
Early Stage Venture
Employee Number:
11-50
Investment Stage:
N/A
Number Of Exists:
N/A
Technology:
Prevention
Investor Type:
N/A
Founded Date:
2002
Industry:
P3 Medicine